Author: bobstorey1958

LaunchPort’s Novel Microdevices Lands Important Funding from Carb-X Global Partnership

Novel Microdevices ( was awarded up to $13.8 million from CARB-X ( for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections such as Chlamydia trachomatis and Neisseria gonorrhoeae. Novel’s new device would diagnose infections in about 25 minutes from a vaginal swab or urine sample, and […]

Read More

Details of Construction Elements Outlined in Port Covington Plans

The next five buildings in Port Covington are scheduled to begin delivering in late 2022. This development phase will have 440,000 sq. ft. of office; 586,000 sq. ft. of residential from 537 total housing units which break down as 367 market-rate residential dwelling units, 89 affordable dwelling units (ADU), and 81 extended-stay units; 116,000 sq. […]

Read More

Port Covington developers, state officials celebrate start of vertical construction in South Baltimore

Renderings of the future neighborhood show foot traffic bustling around the parks, shops and eateries. Central to the design is Rye Street Market, a large, mixed-use office building and food hub designed with Baltimore’s rich legacy of open-air markets. Designs also feature breweries, “extended stay” units, wide sidewalks and entertainment venues. The neighborhood is currently […]

Read More

Podcast by Ready Robotics CEO Ben Gibbs

LaunchPort Resident discusses history, growth and future outlook of Ready Robotics on “Automating the Chain” talk show.  In this episode, Tee sits down with Benjamin Gibbs, Co-Founder and CEO of READY Robotics to talk about making robotics user-friendly to spark the future of industrial automation. Automating The Chain bridges the learning gap between business executives […]

Read More

The LaunchPort virtual resident Brevitest moves closer to launch of COVID-19 Antibody test

BreviTest Technologies announced that the FDA has officially accepted BreviTest’s notification of its intent to commercially distribute its IgG antibody test.  The BreviTest SARS-CoV-2 IgG Test detects the presence of SARS-CoV-2 specific IgG antibodies in plasma or serum using only 3μl of sample. Reliable results are available in 10 minutes. A positive test result indicates prior […]

Read More

CoapTech Closes $7M Series B Investment

CoapTech announced the closing of a Series B investment of $7 million led by medical device venture capital firm Hunniwell Lake Ventures. They will use funds to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement. News Article

Read More

LaunchPort Recognized by Baltimore Business Journal for Best in Tech 2020

Congratulations to all of the companies being recognized as winners of this year’s Best in Tech Awards for your work to advance Baltimore’s tech industry. The honorees, who were chosen by BBJ staff, represent the incredible, growing tech ecosystem here in Baltimore, one fueled by world-class assets, phenomenal talent and a commitment to excellence. Baltimore […]

Read More
brevistest device

Brevitest Technologies Becomes First Remote Resident of Baltimore’s LaunchPort™ Manufacturing Accelerator

The LaunchPort™ announced today that Brevitest Technologies will become the latest out-of-state company to partner with the device accelerator. Brevitest has developed a point-of-care analyzer capable of accurately performing enzyme-linked immunosorbent assays (ELISAs), the gold standard for measuring concentrations of molecules in solution. Unlike ELISAs done in laboratories, the technology is portable with a run […]

Read More
Get Started

Let’s build something together.

The LaunchPort | Copyright 2020 | All rights reserved